RESOLVE
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of RESOLVE's published strategy and is not endorsed by, or produced in cooperation with, RESOLVE. Company website
Strategic priorities
RESOLVE operates across 4 stated priorities, with the most concrete near-term plan anchored on lab 4.0 automation excellence.
Transition MC2 platform to a fully automated benchtop solution eliminating manual interventions, enabling "true multi-modality" combining RNA detection (330 targets) with cyclic immuno-fluorescence for protein markers.
Build a "Digital First" organizational model with dedicated Chief Data AI Officer to position the informatics pipeline as a core product, use deep learning algorithms for cell segmentation and spatial analysis.
Scale dual-hub operations (Monheim R&D/manufacturing, San Jose commercial services) to serve pharmaceutical R&D hubs globally, with strategic EDBI investment signaling Asia-Pacific expansion intent.
-
01
Lab 4.0 Automation Excellence
Transition MC2 platform to a fully automated benchtop solution eliminating manual interventions, enabling "true multi-modality" combining RNA detection (330 targets) with cyclic immuno-fluorescence for protein markers.
-
02
AI-Driven Informatics Leadership
Build a "Digital First" organizational model with dedicated Chief Data AI Officer to position the informatics pipeline as a core product, use deep learning algorithms for cell segmentation and spatial analysis.
-
03
Global Commercial Expansion
Scale dual-hub operations (Monheim R&D/manufacturing, San Jose commercial services) to serve pharmaceutical R&D hubs globally, with strategic EDBI investment signaling Asia-Pacific expansion intent.
-
04
Multi-Modal Platform Evolution
Evolve from MC1 to MC2 architecture with expanded scanning area, advanced controls, and FFPE/fresh-frozen sample compatibility to address clinical pathology workflow requirements.
Challenges we see
- Operations Manufacturing
Cyclic Workflow Operational Bottleneck
The smFISH process is inherently iterative—each detection round involves fluidic steps (hybridization, washing, stripping) followed by high-resolution imaging, creating throughput constraints governed by physical chemistry rather than digital processing.
Progressive loss of RNA molecules over multiple cycles (estimated ~40% over 10 cycles) requires precise optimized chemistry; system throughput is fundamentally limited by the number of targets and fluidics speed.
- Digital Integration
Data Deluge and Computational Overhead
The imaging-based nature of Molecular Cartography generates massive volumes of high-resolution data—a single experiment can produce terabytes of raw image files requiring state-of-the-art deep learning algorithms for cell segmentation.
Computationally intensive workloads demand significant local or cloud-based hardware; any "dropped images" or "imperfections in transcript detection probability" can undermine final data quality.
- Digital Operations
Informatics Pipeline Fragmentation
Users must independently manage "Image processing and decoding," "Cell segmentation and read assignment," and "Cell type identification" steps across disconnected toolsets, with limited standardization.
Integrating specialized spatial datasets with existing customer data architectures (e.g., scRNA-seq references) remains a significant challenge requiring advanced bioinformatics support unavailable to many customers.
- Compliance Regulatory
Clinical Regulatory Transition
As spatial biology moves from "Discovery-focused" research toward "Clinical laboratory use," requirements for IVDR (Europe) and CLIA (US) compliance become increasingly stringent for cancer diagnostics and pathology applications.
The move to clinical use requires digital traceability, quality control, and standardized analysis workflows currently still in development across the entire spatial omics industry, creating a barrier to market entry.
- Operations Operations
Multi-Site Service Coordination
Managing global sample logistics and data delivery across San Jose and Monheim service laboratories creates operational complexity as the company scales from research services to pharmaceutical screening contracts.
Without unified visibility into sample work through the Molecular Cartography workflow—from intake to "My Resolve" portal delivery—operational friction increases and customer trust becomes harder to maintain.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Disconnected Global Laboratory Operations
Resolve's San Jose and Monheim service laboratories operate as primary revenue drivers but lack unified digital visibility into sample status, workflow progress, and data delivery timelines across geographically distributed sites.
Implement a unified digital "Control Tower" providing real-time visibility into every sample's work through the Molecular Cartography workflow, enabling proactive customer communication and operational optimization.
-
Manual MC2 Workflow Interventions
Despite the MC2 being marketed as "fully automated," the platform still requires significant human intervention for sample preparation and data hand-off, limiting throughput for large-scale pharmaceutical screening contracts.
Develop an "Automated Lab-in-a-Box" orchestration layer that links MC2 fluidics with external robotic sample preparation units, enabling higher throughput and reduced operational constraints.
-
Clinical AI Validation Gap
Cell segmentation—a computationally intensive task critical to Molecular Cartography data quality—relies on deep learning algorithms that lack GxP validation frameworks required for clinical diagnostics adoption.
Create a "Validated AI" platform for cell segmentation and transcript decoding designed specifically for GxP compliance, featuring explainable AI (XAI) models to satisfy clinical regulatory requirements.
-
IT/OT Manufacturing Silos
As Resolve scales manufacturing of Molecular Cartography reagents and hardware, the shop-floor operational technology (fluidics and assembly lines) remains disconnected from enterprise-level information technology (ERP, supply chain management).
Integrate manufacturing OT with enterprise IT systems using Industry 4.0 standards, enabling predictive quality control, supply chain optimization, and smooth scaling of global production capacity.
-
Cloud-Native Informatics Scalability
The computational demands of spatial transcriptomics data processing require scalable infrastructure that can handle terabytes of image data, yet Resolve's informatics pipeline lacks cloud-native architecture for elastic scaling.
Develop cloud-native bioinformatics infrastructure following the OMAPiX/Oracle Cloud model, enabling "Smart Segmentation" tools with A4BEE machine learning expertise to automate cell segmentation across diverse tissue types.
What we'd propose
- Digital Lab
Unified Laboratory Control Tower Platform
A comprehensive digital orchestration platform providing end-to-end visibility and control across Resolve's distributed laboratory operations, from sample intake through data delivery to the "My Resolve" portal.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Automated Workflow Orchestration Architecture
An "Automated Lab-in-a-Box" solution that integrates MC2 instrument control with robotic sample preparation, automated scheduling, and closed-loop quality monitoring to maximize throughput for pharmaceutical screening contracts.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
GxP-Validated AI Analysis Platform
A regulatory-compliant artificial intelligence platform for cell segmentation and transcript decoding, featuring explainable AI models designed specifically to meet IVDR and CLIA requirements for clinical spatial diagnostics.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Manufacturing IT/OT Convergence Platform
A comprehensive integration architecture bridging Resolve's shop-floor operational technology (MC2 fluidics, reagent manufacturing, assembly lines) with enterprise information systems (ERP, supply chain, quality management).
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Cloud-Native Bioinformatics Infrastructure
A scalable, cloud-native data platform for spatial transcriptomics analysis, providing elastic compute resources for image processing, standardized bioinformatics pipelines, and secure multi-tenant data management.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what RESOLVE's own published ambition implies — not a perfect score.
- Data Integration 45 → 85
- Spatial datasets remain siloed from customer reference data; terabyte-scale imaging data lacks unified pipeline to enterprise systems.
- Process Automation 55 → 90
- MC2 marketed as "fully automated" but requires significant manual intervention for sample prep and data handoff; cyclic workflow not orchestrated end-to-end.
- Cloud Architecture 40 → 85
- Partner OMAPiX moved to Oracle Cloud, but Resolve's core informatics infrastructure not cloud-native; lacks elastic scaling for computational workloads.
- AI/ML Maturity 50 → 90
- Deep learning used for cell segmentation but lacks GxP validation; "Black Box" concerns from Chief Data AI Officer indicate need for explainable AI.
- Regulatory Digitalization 35 → 80
- IVDR/CLIA compliance infrastructure not yet built; clinical market entry requires digital traceability and QMS automation currently absent.
- IT/OT Convergence 40 → 85
- Manufacturing OT (fluidics, assembly) disconnected from enterprise IT; leadership's operational excellence vision requires unified architecture.
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
Think we've read this right?
Talk to usRelated reading
-
Lab of Tomorrow: We’re at a Turning Point – Is Your Lab on the Right Track?
Do you know what the biggest paradox is? Biotech and pharma fully understand that digitization is the future. Most of them know that effective market competition is simply not possible without artificial intelligence, automation, and data analysis. And yet, many labs are still stuck in the past, working in isolation, manually analyzing data, and losing the potential that technology offers.
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
-
Digital Twin Maturity Model – self-assessment tool
Initially, defining what a digital twin even is seemed simple - we have a real product and its virtual counterpart, and we combine the two.
-
How to spread UX culture inside a life science organization?
UX culture is not only about design or research; it’s about building products and services tailored to the user.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with RESOLVE, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].